Clinical Trials on Car Seat Installation in Liechtenstein
Total 0 results
Nothing found
Sponsors and Collaborators
- EXCELYA Bordeaux
- Canadian Glycomics Network (GlycoNet)
- Diabetes Research Institute, Munich, Germany.
- Rivus Pharmaceuticals, Inc.
- Phoenix VA Health Care System
- Hospital Santos Reyes de Aranda de Duero, Burgos
- South Texas Health System McAllen
- Orthopädisch-Unfallchirurgische Praxis Dr Lembeck & Dr Pampel
- Critical Care Pharmacotherapy Trials Network
- Clinic of the International Institute of Postgraduate Education Ministry of Healthcare of the Republic of Kazakhstan
- kıvan çevik kaya
- Dr. Khaled Ahmed Yassen
- EndoTheia
- Jinxiang County People's Hospital
- Department of Orthopedics, Norrköping
- Pearl Network
- Retina Foundation of Canada
- Bettina Eiger
- Merve Şeker
- Alcohol Education and rehabilitation Fund
- View Full List
Medical Conditions
- Acute Upper Gastrointestinal Non Variceal Hemorrhage
- Cystic Renal Disease
- Fluorescein Angiography
- Acute Rotator Cuff Tear Related to Trauma
- Secondary Pulmonary Arterial Hypertension
- Dystonic Disorders
- Morton's Neuroma
- Newborn Infants
- Tumor Cell, Circulating
- Ruptured Achilles Tendon
- Myocardial Infarction (MI) or Acute Myocardial Infarction (AMI)
- Myocardial Haemorrhage
- Encephalitis, Arbovirus
- Presence / Absence of EBV
- Deep Neck Space Infections
- Racial Bias
- 1- Primary (Sarcomeric) Hypertrophic Cardiomyopathy
- Malignant Pelvic Neoplasm
- Poststroke Fatigue
- Organic Anion Transporting Polypeptide1B1 (OATP1B1)
- View Full List
Drug Interventions
- Tenofovir
- Anastrozole
- Cetuximab
- Ketamine 0.3 mg/kg at anesthesia induction
- Sipuleucel-T
- Amisulpride Oral Tablet
- Tranexamic acid
- PCO371
- Sodium Nitroprusside
- Follitropin beta liquid formulation
- Visanne (Dienogest, BAY86-5258)
- Percutaneous sirolimus
- Modified Bolus 5-FU/LV with Irinotecan
- 5.0g SRT501
- Trastuzumab in combination with SubQ GM-CSF
- 6-Mercaptopurine
- Vinorelbine tartrate
- Nicoderm C-Q Transdermal Product
- Granulocyte colony-stimulating factor
- 30 mg CVL-231 as slow-release MR formulation
- View Full List
CROs by country
- Contract Research Organizations in Belarus
- Contract Research Organizations in Bulgaria
- Contract Research Organizations in Burkina Faso
- Contract Research Organizations in Chile
- Contract Research Organizations in Cote d'Ivoire
- Contract Research Organizations in Czech Republic
- Contract Research Organizations in Hungary
- Contract Research Organizations in Malawi
- Contract Research Organizations in Mongolia
- Contract Research Organizations in Rwanda
- Contract Research Organizations in Spain
- Contract Research Organizations in Sri Lanka
- Contract Research Organizations in Suriname
- CRO list by country